Microvascular Angina

Microvascular angina: angina that predominantly affects women

In women receiving evaluation for suspected ischemic symptoms, a "normal" diagnosis is five times more common than it is in men. These women are often labeled as having cardiac syndrome X, also known as microvascular angina (MVA). MVA is defined as angina pectoris caused by abnormalities of the small coronary arteries, and is characterized by effort chest pain and evidence of myocardial ischemi...

Microvascular Angina (Cardiac Syndrome X)

The prevalence of microvascular angina is estimated to be up to 30% of stable angina patients with non-obstructive coronary arteries. 19% of women presenting with acute coronary syndrome, 30% of women presenting with unstable angina, 9.1% of women with non-STelevation myocardial infarction and 10% of women with ST-elevation myocardial infarction were determined to have normal or nonobstructive ...

Microvascular Angina (Cardiac Syndrome X)

The prevalence of microvascular angina is estimated to be up to 30% of stable angina patients with nonobstructive coronary arteries. 19% of women presenting with acute coronary syndrome, 30% of women presenting with unstable angina, 9.1% of women with non-ST-elevation myocardial infarction and 10% of women with ST-elevation myocardial infarction were determined to have normal or non-obstructive...

Microvascular angina: a women's affair?

Correlation between coronary microvascular function and angina status in patients with stable microvascular angina.

BACKGROUND Classical anti-ischemic drugs are the first-line form of treatment in patients with microvascular angina (MVA), but they often fail to achieve a satisfactory control of angina symptoms. It is unknown whether there is any relation between improvement of angina status and changes in microvascular function induced by classical anti-ischemic drugs in MVA patients. AIM To assess whether...